Influence of interleukin-10 polymorphism on the development of coronary vasculopathy following cardiac transplantation

Transplant Immunology

Volumn 11, Issue 2, 2003, Pages 223-228

  Densem, C G ^a   Hutchinson, I V ^b   Yonan, N ^a   Brooks, N H ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cardiac transplantation; Coronary vasculopathy; Interleukin 10; Polymorphism

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DNA; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL;

ACUTE GRAFT REJECTION; AGE; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROPHORESIS; EPICARDIUM; FEMALE; GENE AMPLIFICATION; GENE ISOLATION; GENETIC RISK; GENOTYPE; HEART TRANSPLANTATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; RECIPIENT; RISK FACTOR;

ANGIOGRAPHY; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-10; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0038376147     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(03)00015-7     Document Type: Article

References (46)

1. Billingham ME. Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis. Transplant Proc 1995;27:2013-2016.
2. Johnson DE, Gao SZ, Schroeder JS, DeCampi WM, Billingham ME. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Lung Transplant 1989;8:349-359.
3. Fiorentino DF, Bond MW, Mossman TR. Two types of mouse T helper cell. IV. TH2 clones secrete a factor that inhibits cytokine production by TH 1 clones. J Exp Med 1989;170:2081.
4. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
5. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
6. Rennick DM. Studies with IL-10 -/- mice. J Leukoc Biol 1997;61:389-396.
7. Moore KW, O'Garra A, De Waal Malfyt R, Vieir P, Mossman TR. Interleukin-10. Annu Rev Immunol 1993;11:165-190.
8. Pinderski Oslund LJ, Hedrick CC, et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 1999;19:2847-2853.
9. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999;85:e17-e24.
10. Pinderski Oslund LJ, Hedrick CC, Olvera T, et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 1999;19:2847-2853.
11. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995;96:2304-2310.
12. Furukawa Y, Matsumori A, Hwang MW, et al. Cytokine gene expression during the development of graft coronary artery disease in mice. Jpn Circ J 1999;63:775-782.
13. Raisanen-Sokolowski A, Glysing-Jensen T, Russell ME. Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: Insights from IL-10 knockout mice. Am J Pathol 1998;153:1491-1500.
14. Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, Mitchell RN. Interleukin-10 (IL-10) augments allograft arterial disease: Paradoxical effects of IL-10 in vivo. Am J Pathol 1999;155:1929-1939.
15. Hutchinson IV, Turner DM, Sankaran D, Awad MR, Sinnott PJ. Influence of cytokine genotypes on allograft rejection. Transplant Proc 1998;30:862-863.
16. Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992;148:3618.
17. Turner D, Grant SCD, Yonan N, et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997;64:776-779.
18. Sankaran D, Asderakis A, Ashraf S, et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999;56:281-288.
19. Asderakis A, Sankaran D, Dyer P, et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: The cytokine effect on transplantation. Transplantation 2001;71:674-677.
20. Gao SZ, Hunt SA, Schroeder JS, Alderman EL, Hill IR, Stinson EB. Early development of accelerated graft coronary artery disease: Risk factors and course. J Am Coll Cardiol 1996;28:673-679.
21. Perry C, Pravica V, Sinnot PJ, Hutchinson IV. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: A technical report. Transplant Immunol 1998;6:193-197.
22. Mottram PL, Han WR, Purcell LJ, McKenzie IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995;59:559-565.
23. Zuo Z, Wang C, Carpenter D, et al. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Transplantation 2001;71:686-691.
24. Lowry RP, Konieczny B, Alexander D, et al. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice. Transplant Proc 1995;27:392-394.
25. Agarwall SK, Marshall GD Jr.. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 2001;21:147-155.
26. Miyaura H, Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002;168:1087-1094.
27. Verhoef CM, Van Roon JA, Vianen ME, Lafeber FP, Bijlsma JW. The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production. Ann Rheum Dis 1999;58:49-54.
28. Richards DF, Fernandez M, Caulfield J, Hawrylowicz CM. Glucocorticoids drive human CD8(+) T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur J Immunol 2000;30:2344-2354.
29. Hodge S, Hodge G, Flower R, Han P. Methyl-prednisolone upregulates monocyte interleukin-10 production in stimulated whole blood. Scand J Immunol 1999;49:548-553.
30. Dozmorov IM, Miller RA. Age-associated decline in responses of naive T cells to in vitro immunization reflects shift in glucocorticoid sensitivity. Life Sci 1999;64:1849-1859.
31. Tomkins PT, Cooper KL, Appleby P, Webber DG. Effect of pharmacological agents on the productions of interleukin-10 by the murine D10.G4.1 TH2 cell line in vitro. Int J Immunopharmacol 1995;17:619-625.
32. Ferraccioli G, Falleti E, De Vita S, et al. Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy. J Rheumatol 1998;25:1874-1879.
33. Kemna MS, Valantine HA, Hunt SA, Schroeder JS, Chen Y-DI, Reaven GM. Metabolic risk factors for atherosclerosis in heart transplant patients. Am Heart J 1994;128:68-72.
34. Kobashigawa JA, Kasiske BL. Hyperlipidaemia in solid organ transplantation. Transplantation 1997;63:331-338.
35. Turner D, Grant SCD, Yonan N, et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997;64:776-779.
36. Brauner R, Nonyama M, Laks H, et al. Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival. J Thorac Cardiovasc Surg 1997;114:923-933.
37. Baan CC, Van Emmerik NEM, Balk AHMM, et al. Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol 1994;97:293-298.
38. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft: A sequential study. Transplantation 1994;57:1333-1337.
39. Nakagawa T, Sukhova GK, Rabkin E, Winters GL, Schoen FJ, Libby P. Acute rejection accelerates graft coronary disease in transplanted rabbit hearts. Circulation 1995;92:287-293.
40. Brock MV, Salazar JD, Cameron DE, Baumgartner WA, Conte JV. The changing profile of the cardiac donor. J Heart Lung Transplant 2001;20:1005-1009.
41. Anyanwu AC, Rogers CA, Murday AJ. Variations in cardiac transplantation: Comparisons between the United Kingdom and the United States. J Heart Lung Transplant 1999;18:297-303.
42. Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors. Cardiac transplant research database. J Heart Lung Transplant 1998;17:744-753.
43. Julius BK, Attenhofer Jost CH, Sutsch G, et al. Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation. Transplantation 2000;69:847-853.
44. Klauss V, Spes CH, Rieber J, et al. Predictors of reduced coronary flow reserve in heart transplant recipients without angiographically significant coronary artery disease. Transplantation 1999;68:1477-1481.
45. Kapadia SR, Nissen SE, Ziada KM, et al. Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis. Comparison by serial intravascular ultrasound imaging. Circulation 1998;98:2672-2678.
46. Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 2000;19:551-556.